Skip to main content
OpenTrials
Completed

NCT Number: NCT04845152

Migraine in Electrohypersensitive Patients

The investigators propose here by the use of the French version of the migraine disease screening questionnaire (ID Migraine ™) to study the prevalence of migraine disease in a population of electrohypersensitive patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed Consent
  • 18 years or older at the time of informed consent

With all these criteria :

  • the perception by the subjects of various non-specific functional symptoms
  • the absence of clinical and biological evidence to explain the symptoms
  • the attribution by the subjects themselves of these symptoms to exposure to electromagnetic fields, which are themselves diverse
  • the symptoms are chronic (more than 3 months)
  • the symptoms appear during an exposure to a source of electromagnetic radiation and cease after the exposure is stopped
  • the symptoms are reproducible

Exclusion criteria

  • age under 18 years old

Treatment and study plan

Primary outcomes

  1. Possible migraine attack

    Time frame: 12 months

    With the number of positive response to the French version of the migraine disease screening questionnaire, we are looking for the patients declaring themselves electrohypersensitive if they have had headaches in the last 12 months with characteristics that could evoke a migraine attack.

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Prevalence of Migraine Disease in Electrohypersensitive Patients

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Apr 14, 2021
Registry last updated
Jun 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.